Endosomal-lysosomal dysfunction in metabolic diseases and Alzheimer's disease

Int Rev Neurobiol. 2020:154:303-324. doi: 10.1016/bs.irn.2020.02.012. Epub 2020 Jul 10.

Abstract

The endosomal-lysosomal pathways and related autophagic processes are responsible for proteostasis, involving complexes between lysosomes and autophagosomes. Lysosomes are a key component of homeostasis, involved in cell signaling, metabolism, and quality control, and they experience functional compromise in metabolic diseases, aging, and neurodegenerative diseases. Many genetic mutations and risk factor genes associated with proteinopathies, as well as with metabolic diseases like diabetes, negatively influence endocytic trafficking and autophagic clearance. In contrast, health-improving exercise induces autophagy-lysosomal degradation, perhaps promoting efficient digestion of injured organelles so that undamaged organelles ensure cellular healthiness. Reductions in lysosomal hydrolases are implicated in Alzheimer's, Parkinson's, and lysosomal storage diseases, as well as obesity-related pathology, and members of the cathepsin enzyme family are involved in clearing both Aβ42 and α-synuclein. Upregulation of cathepsin hydrolases improves synaptic and memory functions in models of dementia and in exercising humans, thus identifying lysosomal-related systems as vital for healthy cognitive aging.

Keywords: Age-related neurodegenerative disorders; Autophagic-lysosomal pathway; Autophagy; Cathepsin B; Endocytic trafficking; Protein accumulation disorders; Proteinopathy; Quality control; Synaptic pathology; Trafficking.

Publication types

  • Review

MeSH terms

  • Aging / metabolism*
  • Alzheimer Disease / metabolism*
  • Animals
  • Diabetes Mellitus / metabolism*
  • Exercise* / physiology
  • Humans
  • Lysosomes / metabolism*
  • Metabolic Diseases / metabolism*
  • Metabolic Networks and Pathways* / physiology
  • Obesity / metabolism*
  • Proteostasis* / physiology
  • Synucleinopathies / metabolism*